Role of transporter genes in cisplatin resistance

In Vivo

Volumn 22, Issue 3, 2008, Pages 279-284

  Konkimalla, V Badireenath ^a   Kaina, Bernd ^b   Efferth, Thomas ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ABC transporter; Cisplatin; Copper transporter; Drug resistance; Microarray; Pharmacogenomics

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; CISPLATIN; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; COPPER ION; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PROTON PUMP;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PROTEIN MICROARRAY;

EID: 45949109339     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Efferth T and Volm M: Protein expression profiles indicative for drug resistance of kidney carcinoma. Cancer Genomics Proteomics 1: 17-22, 2004.
2. Efferth T, Koomägi R, Mattern J and Volm M: Lung cancer protein expression profiles of smokers and non-smokers. Cancer Genomics Proteomics 1: 249-254, 2004.
3. Volm M, Koomägi R and Efferth T: Prediction of drug sensitivity and resistance of cancer by protein expression profiling. Cancer Genomics Proteomics 1: 157-166, 2004.
4. Uchiumi T, Hinoshita E, Haga S, Nakamura T, Tanaka T, Toh S, Furukawa M, Kawabe T, Wada M, Kagotani K, Okumura & Kohno K, Akiyama S and Kuwano M: Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem Biophys Res Commun 252: 103-110, 1998.
5. Borst P, Evers R, Kool M and Wijnholds J: A family of drug transporters: the multidrug resistance-associated proteins. J Nad Cancer Inst 92: 1295-1302, 2000.
6. Safaei R and Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 53: 13-23, 2005.
7. Murakami T, Shibuya I, Ise T, Chen ZS, Akiyama S, Nakagawa M, Izumi H, Nakamura T, Matsuo & Yamada Y and Kohno K: Elevated expression of vacuolar proton pump genes and cellular pH in cisplatin resistance. Int J Cancer 93: 869-874, 2001.
8. Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, Federici C, Iessi E, Parmiani G, Arancia G, Belardelli F and Fais S: Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 96: 1702-1713, 2004.
9. +-dependent glutamate and aspartate transporter supports glutathione maintenance and survival of CHO-K1 cells. Somat Cell Mol Genet 24: 341-352, 1998.
10. Sugiyama T and Sadzuka Y: Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents. Biochim Biophys Acta 1653: 47-59, 2003.
11. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244, 2000.
12. Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES and Golub TR: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98: 10787-10792, 2001.
13. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DI, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988.
14. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A and Boyd MR: Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82: 1113-1118, 1990.
15. Szakacs G, Annereau JP, Lababidi S, Shankavararn U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN and Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004.
16. Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279, 2003.
17. Rabik CA and Dolan ME: Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33: 9-23, 2007.
18. Efferth T: The human ATP-binding cassette transporter genes: from the bench to the bedside. Curr Mol Med 1: 45-65, 2001.
19. Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V and Remacle J: Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res 64: 8987-8993, 2004.
20. Efferth T, Chen Z, Kaina B and Wang G: Molecular determinants of response of tumor cells to berberine. Cancer Genomics Proteomics 2: 115-124, 2005.
21. Steinbach D, Gillet JP, Sauerbrey A, Gruhn B, Dawczynski K, Bertholet V, de Longueville F, Zintl F, Remacle J and Efferth T: ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res 12: 4357-4363, 2006.
22. Efferth T, Gillet JP, Sauerbrey A, Zintl F, Bertholet V, de Longueville F, Remacle J and Steinbach D: Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 5: 1986-1994, 2006.
23. Gillet JP, Schneider J, Bertholet V, de Longueville F, Remacle J and Efferth T: Microarray expression profiling of ABC transporters in human breast cancer. Cancer Genomics Proteomics 3: 97-106, 2006.
24. Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao, H, Miura N, Sugiyama T and Akiyama S: Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 60: 1312-1316, 2000.
25. Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M and Howell SB: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669, 2004.
26. Samimi G, Katano K, Holzer AK, Safaei R and Howell SB: Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol Pharmacol 66: 25-32, 2004.
27. Safaei R and Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 53: 13-23, 2005.
28. Holzer A-K, Manorek GH and Howell SB: Contribution of the major copper influx transporter CTR1. to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Mol Pharmacol 70: 1390-1394, 2006.
29. Holzer AK, Varki NM, Le QT, Gibson MA, Naredi P and Howell SB: Expression of the human copper influx transporter 1 in normal and malignant human tissues. J Histochem Cytochem 54: 1041-1049, 2006.
30. Kanzaki A, Toi M, Neamati N, Miyashita H, Oubu M, Nakayama K, Bando, H, Ogawa K, Mutoh M, Mori S, Terada K, Sugiyama T, Fukumoto M and Takebayashi Y: Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma. Jpn J Cancer Res 93: 70-77, 2002.
31. Nakayama K, Kanzaki A, Ogawa K, Miyazaki K, Neamati N and Takebayashi Y: Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer 101: 488-495, 2002.
32. Aida T, Takebayashi Y, Shimizu T, Okamura C, Higasimoto M, Kanzaki A, Nakayama K, Terada K, Sugiyama T, Miyazaki K, Ito K, Takenoshita S and Yaegashi N: Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas. Ann lborac Cardiovasc Surg 11: 143-145, 2005.
33. Miyashita H, Nitta Y, Mori S, Kanzaki A, Nakayama K, Terada K, Sugiyama T, Kawamura H, Sato A, Morikawa H, Motegi K and Takebayashi Y: Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance, marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol 39: 157-162, 2003.
34. Higashimoto M, Kanzaki A, Shimakawa T, Konno S, Naritaka Y, Nitta Y, Mori S, Shirata S, Yoshida A, Terada K, Sugiyama T, Ogawa K and Takebayashi Y: Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma. Int J Mol Med 11: 337-341, 2003.
35. Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS and Howell SB: Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res 9: 5853-5859, 2003.